Published in

Royal Society of Chemistry, Toxicology Research, 4(4), p. 777-795

DOI: 10.1039/c4tx00238e

Links

Tools

Export citation

Search in Google Scholar

Towards the development of mechanism-based biomarkers to diagnose drug hypersensitivity

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

T-cells are activated by different mechanisms in the presence of drugs, metabolites or haptens, and they release several molecules that can be used in the diagnosis of drug hypersensitivity.